Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,159 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Estimands in hematologic oncology trials.
Sun S, Weber HJ, Butler E, Rufibach K, Roychoudhury S. Sun S, et al. Among authors: butler e. Pharm Stat. 2021 Jul;20(4):793-805. doi: 10.1002/pst.2108. Epub 2021 Mar 8. Pharm Stat. 2021. PMID: 33686762
Caveolin-1 regulates context-dependent signaling and survival in Ewing Sarcoma.
Segal D, Wang X, Mazloom-Farsibaf H, Rajendran D, Butler E, Chen B, Chang BJ, Ahuja K, Perny A, Bhatt K, Reed DK, Castrillon D, Lee J, Jeffery E, Wang L, Nguyen K, Williams NS, Rajaram S, Fiolka RP, Jaqaman K, Skapek SX, Hon GC, Amatruda J, Danuser G. Segal D, et al. Among authors: butler e. bioRxiv [Preprint]. 2024 Dec 12:2024.09.23.614468. doi: 10.1101/2024.09.23.614468. bioRxiv. 2024. PMID: 39713413 Free PMC article. Preprint.
RESILIENCE (Retrospective Linkage Study of Autoimmune Encephalitis): protocol for an Australian retrospective cohort study of outcomes in autoimmune encephalitis using data linkage techniques.
Halliday AJ, Lambert K, Bundell C, McLean-Tooke A, Gillis D, Prain KM, Bryson G, Gillinder L, Brown D, Ramanathan S, Dale R, Brilot F, Jordan N, Lawn N, Lai A, Boyd J; Australian Adult Comprehensive Epilepsy Centres Consortium; Camacho X, D'Souza WJ. Halliday AJ, et al. BMJ Open. 2024 Dec 5;14(12):e084664. doi: 10.1136/bmjopen-2024-084664. BMJ Open. 2024. PMID: 39638600 Free PMC article.
Switching treatment to cipaglucosidase alfa plus miglustat positively affects patient-reported outcome measures in patients with late-onset Pompe disease.
Kishnani PS, Byrne BJ, Claeys KG, Díaz-Manera J, Dimachkie MM, Kushlaf H, Mozaffar T, Roberts M, Schoser B, Hummel N, Kopiec A, Holdbrook F, Shohet S, Toscano A; PROPEL Study Group. Kishnani PS, et al. J Patient Rep Outcomes. 2024 Nov 13;8(1):132. doi: 10.1186/s41687-024-00805-w. J Patient Rep Outcomes. 2024. PMID: 39535661 Free PMC article. Clinical Trial.
1,159 results